Our website uses cookies to improve your on-site experience. By using the website, cookies are being used as described in our Policy Document
Warning: To log in you will need to enable cookies and reload the page (Policy Document)
My ePortfolio Register   

The growing role of precision and personalised medicine for cancer treatment

In a paper published in the journal TECHNOLOGY, a group of researchers from Rutgers University Department of Biomedicine Engineering have published a review paper on the transformative potential of precision and personalised medicine (PPM) for cancer treatment.

A group of Rutgers PhD fellows and faculty published a review paper on the transformative potential of precision and personalised medicine (PPM) for cancer treatment.

Their analysis considers the entire process from acquiring PPM data, to developing a PPM product, and addresses broader economic and societal consequences. 

A primary message of the paper is that PPM has the potential to transform cancer care.

The traditional model is limited to tumour detection, followed by general treatment procedures such as surgery, chemotherapy, and radiation.

In contrast, the PPM approach allows for targeted treatments, which are more effective and avoid unnecessary side effects.

These treatments are identified by analysing specific tissues, gene mutations, and personal factors relevant to each unique case of cancer.

Examples of such emerging treatments include immunotherapies, cancer vaccines, companion diagnostics, and more.

In addition, the authors addressed societal issues of PPM in healthcare.

Although potentially transformative, a lot of difficult questions must be answered before PPM becomes part of standard cancer care.

These include regulatory challenges, economic concerns and feasibility, and associated socioeconomic and privacy issues.

Today, PPM technology exists and is rapidly becoming more efficient and sophisticated; however, these questions must be tackled in order to allow for the smooth integration of PPM into cancer care.

Source: World Scientific

0

Comments

Please click on the 'New Comment' link to the left to add a new comment, or alternatively click any 'Add Comment' link next to any existing post to respond. The views expressed here are not those of ecancer. For more information please view our Privacy Policy.



Founding partners

European Cancer Organisation European Institute of Oncology

Founding Charities

Foundazione Umberto Veronesi Fondazione IEO Swiss Bridge

Published by

ecancer Global Foundation